Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/07/055093
CTRI/2023/07/055093
Not yet recruiting
Phase 3

comparative study of the effect of aprepitant vs ondansetron in preventing post operative nausea and vomiting in laparoscopic surgery a prospective, randomized double blind control study

Dr. Sathya priya0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K352- Acute appendicitis with generalized peritonitisHealth Condition 2: K800- Calculus of gallbladder with acutecholecystitisHealth Condition 3: N800- Endometriosis of uterus

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K352- Acute appendicitis with generalized peritonitisHealth Condition 2: K800- Calculus of gallbladder with acutecholecystitisHealth Condition 3: N800- Endometriosis of uterus
Sponsor
Dr. Sathya priya
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr. Sathya priya

Eligibility Criteria

Inclusion Criteria

  • •ASA 1 and 2
  • •UNDERGOING LAPAROSCOPIC SURGERY UNDER GA LESS THAN 4 HOUR

Exclusion Criteria

  • •PATIENT REFUSAL
  • •ASA 3 AND 4
  • •ON ANY OTHER DRUG CAUSING EMESIS
  • •KNOWN TO CAUSE ALLERGY TO ABOVE DRUGS
  • •PATIENT WHO IS ALREADY ON ANTI EMETIC DRUGS

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of combinational effect of Aprepitant on nausea and vomiting induced by chemotherapy (moderate risk) in patients with Gastric Cancer or Colorectal CancerInoperable advanced/recurrence Gastric Cancer or Colorectal Cancer
JPRN-UMIN000008041Osaka Medical College Hospital100
Not yet recruiting
Not Applicable
Aprepitant as a premedication for prevention of post operative nausea and vomiting (PONV).Health Condition 1: O- Medical and Surgical
CTRI/2021/11/037883JSS MEDICAL COLLEGE AND HOSPITA
Completed
Not Applicable
Evaluation of combinational effect of Aprepitant and Dxamethasone on nausea and vomiting induced by high-emetic-risk chemotherapy in patients.
JPRN-UMIN000010818Osaka Medical College Hospital200
Recruiting
Phase 3
The effect of Apotel and Ketorolac on pain after surgeryPain after laparoscopic cholecystectomy.
IRCT20101211005362N30Esfahan University of Medical Sciences90
Completed
Not Applicable
The effect of oral Aprepitant and Ondansetron injection on postoperative nausea and vomiting
IRCT2016120831302N1Vice President of Research, Kurdistan University of Medical Sciences90